IL12B and Pancytopenia: CpG-injected WT mice receiving double treatment, show improvement in pancytopenia (Fig. 8A), hepatosplenomegaly (Fig. 8B), and liver inflammation (Fig. 8C and D), with reduced expression of inflammatory cytokines (Il6, Il12b, and Tnfa) (Fig. 8E) compared with untreated mice.